ArticleFrontiers in oncology2024

A new, potential and safe neoadjuvant therapy strategy in epidermal growth factor receptor mutation-positive resectable non-small-cell lung cancer-targeted therapy: a retrospective study.

Baoxing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.